T

The Eleven Fund

5 employees

Late Stage PreIPO fund

Investor insights

Sectors invested in

Pharmaceutical2
Biotechnology2
Software2
Therapeutics2
Medical1
Cannabis1
Information Technology1
Digital Healthcare1
Neurogaming1
Mobile Healthcare1
Opiate Dependence1
mHealth1
Substance Use Disorder1
Pharmaceuticals1

Funding rounds participated in

$120M sweet spot round size

Most of their 3 investments are in rounds between $40M and $120M

Investor type

Private Equity Firm

Basic info

Industry

financial services

Date founded

2017

Investments made

E

Escient Pharmaceuticals raised $120M on November 28, 2022

Investors: Osage University Partners (OUP), Redmile Group, The Column Group, Sanofi Ventures, Avego Healthcare Capital, Partner Fund Management and The Eleven Fund

A

Alleaves raised $40M on July 19, 2022

Investors: The Eleven Fund

P

Pear Therapeutics raised $125M on December 3, 2021

Investors: Pritzker Vlock Family Office, QUAD Investment Management, SoftBank Investment Advisers, Trustbridge Partners, Shanda Group, Temasek and The Eleven Fund

FAQ